Neyssa Marina
Publication Details
-
Anti-insulin growth factor receptor therapy in Ewing sarcoma.
F1000 Med Rep. 2009
The insulin-like growth factor (IGF) signal transduction pathway appears to play a key role in the development and proliferation of the Ewing sarcoma family of tumors. Integration of anti-IGF-1 receptor therapy into the standard treatment for these patients is a novel approach that will likely be incorporated into future treatment to determine whether such agents will improve the outcome for patients with this malignancy.
Help
Trial Administration